Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log

This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record.

November 11, 2024

Reassessed

Methyldopa (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

CYB005 (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
KM-391 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Obecabtagene autoleucel (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
Draft:Psychedelic Medicine (talk) assessed. Importance assessed as NA-Class. (rev · t)
VU0530244 (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)

November 10, 2024

Reassessed

Dihydroxyphenylglycine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Maharashtra State Pharmacy Council (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Metiamide (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Removed

Draft:Felix Effah (talk) removed.

November 9, 2024

Reassessed

CAd3-ZEBOV (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Clorotepine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Pandinotoxin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Phenazopyridine (talk) reassessed. Quality rating changed from Start-Class to B-Class. (rev · t)

November 8, 2024

Renamed

3-Methylbutanoic acid renamed to Isovaleric acid.

Reassessed

Bavdegalutamide (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
Fazamorexant (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
The Shulgin Index (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
Vafidemstat (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
XW10508 (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)

Assessed

Amphetamine type stimulant (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Isovaleric acid (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Pharmacology of ethanol (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
UH15-38 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

November 7, 2024

Reassessed

Category:Amphetamines (talk) reassessed. Quality rating changed from Category-Class to Redirect-Class. (rev · t)
Anthraquinone (talk) reassessed. Quality rating changed from Stub-Class to B-Class. (rev · t)
Crisnatol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

Vafidemstat (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

November 6, 2024

Reassessed

5-MBPB (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
AAZ-A-154 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Alpertine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Ariadne (drug) (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
Ciclindole (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Drug discrimination (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
LSM-775 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
MYCO-005 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Metitepine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Oxypertine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

Bexirestrant (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Category:Drug manufacturing (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)

November 5, 2024

Assessed

3-Methoxymethcathinone (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Amcenestrant (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Drug discrimination (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Giredestrant (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Palazestrant (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)